CYP2C9 c.383T>G ;(p.L128R)

Variant ID: 10-96702000-T-G

NM_000771.3(CYP2C9):c.383T>G;(p.L128R)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


The genetic landscape of major drug metabolizing cytochrome P450 genes-an updated analysis of population-scale sequencing data.

The Pharmacogenomics Journal
Zhou, Yitian Y; Lauschke, Volker M VM
Publication Date: 2022-12

Variant appearance in text: CYP2C9: 383T>G; Leu128Arg; rs1375956433
PubMed Link: 36068297
Variant Present in the following documents:
  • 41397_2022_288_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.

Blood
Chen, Xuejie X; Jin, Da-Yun DY; Stafford, Darrel W DW; Tie, Jian-Ke JK
Publication Date: 2018-11-01

Variant appearance in text: CYP2C9: L128R
PubMed Link: 30089628
Variant Present in the following documents:
  • Main text
View BVdb publication page



Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.

Journal Of Thrombosis And Haemostasis : Jth
Tie, J-K JK; Jin, D-Y DY; Tie, K K; Stafford, D W DW
Publication Date: 2013-08

Variant appearance in text: CYP2C9: L128R
PubMed Link: 23710884
Variant Present in the following documents:
  • Main text
View BVdb publication page